Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing

• Published in: International journal of antimicrobial agents 2022-01, Vol.59 (1), p.106456-106456, Article 106456
• Main Authors: Arca-Suárez, Jorge, Rodiño-Janeiro, Bruno K., Pérez, Astrid, Guijarro-Sánchez, Paula, Vázquez-Ucha, Juan C., Cruz, Fernando, Gómez-Garrido, Jèssica, Alioto, Tyler S., Álvarez-Tejado, Miguel, Gut, Marta, Gut, Ivo, Oviaño, Marina, Beceiro, Alejandro, Bou, Germán, Merino, Irene, Cercenado, Emilia, Gómez, Rosa, Soler, Tamara, Gracia-Ahufinger, Irene, Martín, Lina, Galán, Fátima, Tormo, Nuria, Rodríguez, Juan Carlos, Capilla, Silvia, Marco, Francesc, Quesada, María Dolores, Padilla, Emma, Tubau, Fe, González, Juanjo, López-Calleja, Ana Isabel, del Pozo, José Luis, García, María Inmaculada, Martinez, Mariela, Calvo, Jorge, Mulet, Xavier, Peña, Fernanda, Rodríguez, Ana Isabel, Gude, María José, Fernández, Ana, Fernández, Javier
• Format: Article
• Language: English
• Subjects: Aminoglycosides; beta-Lactamases - genetics; beta-Lactamases - metabolism; Carbapenemases; Drug Resistance, Bacterial - genetics; Enterobacterales; Enterobacteriaceae - genetics; Enterobacteriaceae - metabolism; Genetic Variation; Genome-Wide Association Study; Genotype; Humans; Methyltransferases; Methyltransferases - genetics; Methyltransferases - metabolism; RNA, Ribosomal, 16S - genetics; Spain
• ISSN: 0924-8579; 1872-7913
• DOI: 10.1016/j.ijantimicag.2021.106456

The emergence of 16S rRNA methyltransferases (RMTs) in Gram-negative pathogens bearing other clinically relevant resistance mechanisms, such as carbapenemase-producing Enterobacterales (CPE), is becoming an alarming concern. We investigated the prevalence, antimicrobial susceptibility, resistance mechanisms, molecular epidemiology and genetic support of RMTs in CPE isolates from Spain. This study included a collection of 468 CPE isolates recovered during 2018 from 32 participating Spanish hospitals. MICs were determined using the broth microdilution method, the agar dilution method (fosfomycin) or MIC gradient strips (plazomicin). All isolates were subjected to hybrid whole-genome sequencing (WGS). Sequence types (STs), core genome phylogenetic relatedness, horizontally acquired resistance mechanisms, plasmid analysis and the genetic environment of RMTs were determined in silico from WGS data in all RMT-positive isolates. Among the 468 CPE isolates evaluated, 24 isolates (5.1%) recovered from nine different hospitals spanning five Spanish regions showed resistance to all aminoglycosides and were positive for an RMT (21 RmtF, 2 ArmA and 1 RmtC). All RMT-producers showed high-level resistance to all aminoglycosides, including plazomicin, and in most cases exhibited an extensively drug-resistant susceptibility profile. The RMT-positive isolates showed low genetic diversity and were global clones of Klebsiella pneumoniae (ST147, ST101, ST395) and Enterobacter cloacae (ST93) bearing blaOXA-48, blaNDM-1 or blaVIM-1 carbapenemase genes. RMTs were harboured in five different multidrug resistance plasmids and linked to efficient mobile genetic elements. Our findings highlight that RMTs are emerging among clinical CPE isolates from Spain and their spread should be monitored to preserve the future clinical utility of aminoglycosides and plazomicin.